Zobrazeno 1 - 10
of 135
pro vyhledávání: '"Marco Tubaro"'
Autor:
Maddalena Ardissino, Adam J. Nelson, Giuseppe Maglietta, Guidantonio Malagoli Tagliazucchi, Caterina Disisto, Patrizia Celli, Maurizio Ferrario, Umberto Canosi, Carlo Cernetti, Francesco Negri, Piera Angelica Merlini, Marco Tubaro, Carlo Berzuini, Chiara Manzalini, Gianfranco Ignone, Carlo Campana, Luigi Moschini, Elisabetta Ponte, Roberto Pozzi, Raffaela Fetiveau, Silvia Buratti, Elvezia Maria Paraboschi, Rosanna Asselta, Andrea Botti, Domenico Tuttolomondo, Federico Barocelli, Serena Bricoli, Andrea Biagi, Rosario Bonura, Tiziano Moccetti, Antonio Crocamo, Giorgio Benatti, Giorgia Paoli, Emilia Solinas, Maria Francesca Notarangelo, Elisabetta Moscarella, Paolo Calabrò, Stefano Duga, Giulia Magnani, Diego Ardissino
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
ImportanceThere is growing awareness of sex-related differences in cardiovascular risk profiles, but less is known about whether these extend to pre-menopausal females experiencing an early-onset myocardial infarction (MI), who may benefit from the p
Externí odkaz:
https://doaj.org/article/885a407af86a408785d5d23d7618d5e0
Autor:
Frans Van de Werf, Jeroen Bax, Amadeo Betriu, Carina Blomstrom-Lundqvist, Filippo Crea, Volkmar Falk, Gerasimos Filippatos, Keith Fox, Kurt Huber, Adnan Kastrati, Annika Rosengren, P. Gabriel Steg, Marco Tubaro, Freek Verheugt, Franz Weidinger, Michael Weis, M. O. Evseev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 5, Pp 73-89 (2016)
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation.
Externí odkaz:
https://doaj.org/article/0bd55076308a417282dc251a77a3ad4b
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 15, Iss 1S, Pp 15-26 (2014)
OBJECTIVES: The aim of this study was to evaluate the cost‑effectiveness of apixaban in the prevention of thromboembolic events in patients with non‑valvular atrial fibrillation (NVAF) relatively to standard of care (warfarin or aspirin) from the
Externí odkaz:
https://doaj.org/article/fdec150737fd4e4f944c7890d2abaed2
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 15, Iss 4, Pp 101-112 (2014)
OBJECTIVES: The study evaluated the cost‑effectiveness of apixaban in preventing thromboembolic events in non‑valvular atrial fibrillation (NVAF) patients, as compared to other three available novel oral anticoagulant agents (NOACs), from the Ita
Externí odkaz:
https://doaj.org/article/0f725c03912d47c9a383d99568796100
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 15, Iss 1S, Pp 5-14 (2014)
OBJECTIVE: This study aims to perform a budget impact analysis of the use of three available novel oral anticoagulant agents (NOACs) for preventing thromboembolic events in Italian patients with non‑valvular atrial fibrillation (NVAF). METHODS: Est
Externí odkaz:
https://doaj.org/article/c8ba489119ea4616a68e2fce73a94a60
Autor:
Stefania Angela Di Fusco, Furio Colivicchi, Nadia Aspromonte, Marco Tubaro, Alessandro Aiello, Massimo Santini
Publikováno v:
Monaldi Archives for Chest Disease, Vol 87, Iss 1 (2017)
Anticoagulation, reducing the risk of thromboembolic events in patients undergoing cardioversion, is a cornerstone of peri-cardioversion management in patients with atrial fibrillation. We aimed to analyse published data on the efficacy and safety of
Externí odkaz:
https://doaj.org/article/922d26054c8f49b3918b22f23289620b
Autor:
Massimo Uguccioni, Francesco Pugliese, Leonardo De Luca, Marco Tubaro, Maria Pia Ruggieri, Furio Colivicchi
Publikováno v:
Monaldi Archives for Chest Disease, Vol 80, Iss 1 (2015)
Consensus Document of the Regional Chapters of the Italian National Association of Hospital Cardiologists (ANMCO) and of the Italian Society of Emergency Medicine (SIMEU) This document has been developed by the Lazio regional chapters of two scienti
Externí odkaz:
https://doaj.org/article/d05fe8e7b1624475b024c42f66b60bc0
Autor:
Ilaria Guella, Rosanna Asselta, Diego Ardissino, Pier Angelica Merlini, Flora Peyvandi, Sekar Kathiresan, Pier Mannuccio Mannucci, Marco Tubaro, Stefano Duga
Publikováno v:
Journal of Lipid Research, Vol 51, Iss 11, Pp 3342-3349 (2010)
The R46L variant in the proprotein-convertase subtilisin-kexin type 9 (PCSK9) gene was associated with reduced levels of LDL and total cholesterol and with a lower risk of coronary artery disease. We investigated the association of R46L with myocardi
Externí odkaz:
https://doaj.org/article/38306413610d46049e9c548036dded5a
Autor:
Ivo Casagranda, Mario Cavazza, Aldo Clerico, Marcello Galvani, Filippo Ottani, Martina Zaninotto, Luigi M. Biasucci, Gianfranco Cervellin, Tiziano Lenzi, Giuseppe Lippi, Mario Plebani, Marco Tubaro
Publikováno v:
Emergency Care Journal, Vol 9, Iss 2, Pp e14-e14 (2013)
The purpose of this document is to develop recommendations on the use of the latest generation of cardiac troponins in emergency room settings for the diagnosis of myocardial infarction in patients with suspected acute coronary syndrome without persi
Externí odkaz:
https://doaj.org/article/057f42b07e0240509477795e9c788d97
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 15, Iss 1S, Pp 3-4 (2014)
Externí odkaz:
https://doaj.org/article/23bd999d739a45c0a72d2196fa66695b